Skip to main content
Caplight Logo









Deliver Biosciences

Deliver Biosciences

Private
LondonHealthcare & Life Scienceshttps://deliverbio.com/

Last Round

Grant

Mar 1, 2022

Company Overview

Deliver Biosciences is a biotechnology company that develops a nanoparticle-based delivery platform to genetically engineer cells inside patients for the creation of scalable, affordable, and potent cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

in vivo gene deliverynanoparticle delivery platformin vivo CAR-Tgene therapycell therapygenetic engineeringbiotech platformdrug deliverylipid nanoparticlesLNPnext-gen biomanufacturingin vivo editingoff-the-shelf cell therapyprecision medicinebiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Deliver Biosciences Comparables

Compare Deliver Biosciences with similar companies based on industry and business-model similarity.

Deliver Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ViaNautis Bio
82%
Ensoma
79%
AbbVie
77%

Deliver Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 1, 2022
SeedDec 1, 2020

Key People

Founding team and executive leadership

Bakul Gupta

Co-founder and CEO

Founding Team

Deliver Biosciences Investors

Notable investors and investment history

Deliver Biosciences investors
InvestorRounds
Deep Science VenturesSeed
SciFoundersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 25, 2025

    Monthly visitors grew 119% MoM.

  • Mar 1, 2022

    Received grant funding to support operations.

Deliver Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Deliver Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Deliver Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range5
Year Founded2019
Last FundingMar 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?